Security key
877619106
Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)
CUSIP: 877619106
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 17,661,042
- Total 13F value
- $358,518,075
- Share change
- -337,509
- SEC-reported price per share
- $20.30
- Number of holders
- 46
- Value change
- -$11,587,017
- Number of buys
- 20
- Number of sells
- 22
- Shares outstanding
- 285,714,286
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
46
Top holders
10
TSHA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Taysha Gene Therapies, Inc. SEC filings
Taysha Gene Therapies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 877619106
Recent filing periods:
Ownership snapshot
Top reported holders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 2%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
2%
BlackRock Finance, Inc.
0.78%
UNIVERSITY OF TEXAS/TEXAS AM INVE...
0.7%
Artal Group S.A.
0.36%
Casdin Capital, LLC
0.29%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
2%
|
$147,862,000
5,664,215 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
0.78%
|
$59,181,000
2,229,816 shares
|
— | 31 Dec 2020 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO |
13F
Company
|
0.7%
|
$53,080,000
2,000,000 shares
|
— | 31 Dec 2020 |
| Artal Group S.A. |
13F
Company
|
0.36%
|
$27,625,000
1,040,882 shares
|
— | 31 Dec 2020 |
| Casdin Capital, LLC |
13F
Company
|
0.29%
|
$21,774,000
820,440 shares
|
— | 31 Dec 2020 |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.29%
|
$21,774,000
820,440 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
17,661,042
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
51
Q1 2021 holders
46
Holder diff
-5
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend